https://ogma.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 P53 in human melanoma fails to regulate target genes associated with apoptosis and the cell cycle and may contribute to proliferation https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:13895 Wed 11 Apr 2018 11:47:28 AEST ]]> Overall survival in metastatic melanoma correlates with pembrolizumab exposure and T cell exhaustion markers https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:46496 Thu 24 Nov 2022 12:14:09 AEDT ]]> Immunotherapy of distant metastatic disease https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:7353 Sat 24 Mar 2018 08:40:18 AEDT ]]> Antiproliferative effects of continued mitogen-activated protein kinase pathway inhibition following acquired resistance to BRAF and/or MEK inhibition in melanoma https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:14877 Sat 24 Mar 2018 08:22:24 AEDT ]]> The BH3-mimetic ABT-737 sensitizes human melanoma cells to apoptosis induced by selective BRAF inhibitors but does not reverse acquired resistance https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:20163 Sat 24 Mar 2018 07:51:41 AEDT ]]> Metastatic acral melanoma treatment outcomes: A systematic review and meta-analysis https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:48478 Mon 20 Mar 2023 09:17:54 AEDT ]]> BRAF mutation testing for patients diagnosed with stage III or stage IV melanoma: practical guidance for the Australian setting https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:47367 Fri 13 Jan 2023 14:57:43 AEDT ]]>